NEW YORK--(BUSINESS WIRE)--Deutsche Bank today announced it has hired Philip Pucciarelli and Robert Verdier, two senior Healthcare Investment Bankers, from BMO Capital Markets.
Pucciarelli will join as Co-Head of Healthcare Investment Banking alongside Ross Hammerman who joined the bank in October 2016. Pucciarelli has nearly 20 years of healthcare investment banking experience, and was most recently Managing Director and Head of Healthcare Services Investment Banking at BMO where he was responsible for leading and expanding BMO’s Healthcare Services platform. Prior to BMO, Pucciarelli spent 12 years at Bank of America Merrill Lynch where he focused on Healthcare Services. He will be based in New York and report to Mark Fedorcik, Head of Corporate Finance Americas and Co-Head of CIB Americas.
Verdier also joins from BMO as a Managing Director in Healthcare Investment Banking reporting to Pucciarelli and Hammerman. He has spent the last year and a half with BMO’s Healthcare Services Investment Banking team focused on community-based healthcare, including providers of consumer/retail health and post-acute care services. Prior to BMO he spent six years at Jefferies and the seven years prior at UBS.
“Healthcare is a clear area of focus and investment for the bank,” said Mark Fedorcik. “These key hires further complement the previous hires we have made to support the opportunity we see in this sector and Deutsche Bank’s overall opportunity to grow its business in the US. We strongly believe the intensity and expertise that Phil and Bob bring to our platform will position us extremely well to offer differentiated strategic advice to our corporate and financial sponsor clients. We look forward to Phil and Bob joining the team this summer.”
Deutsche Bank announced last month that it hired Glenn Rewick as an MD in M&A focusing on Healthcare.
About Deutsche Bank
Deutsche Bank provides commercial and investment banking, retail banking, transaction banking and asset and wealth management products and services to corporations, governments, institutional investors, small and medium-sized businesses, and private individuals. Deutsche Bank is Germany’s leading bank, with a strong position in Europe and a significant presence in the Americas and Asia Pacific.
This release contains forward-looking statements. Forward-looking statements are statements that are not historical facts; they include statements about our beliefs and expectations and the assumptions underlying them. These statements are based on plans, estimates and projections as they are currently available to the management of Deutsche Bank. Forward-looking statements therefore speak only as of the date they are made, and we undertake no obligation to update publicly any of them in light of new information or future events.
By their very nature, forward-looking statements involve risks and uncertainties. A number of important factors could therefore cause actual results to differ materially from those contained in any forward-looking statement. Such factors include the conditions in the financial markets in Germany, in Europe, in the United States and elsewhere from which we derive a substantial portion of our revenues and in which we hold a substantial portion of our assets, the development of asset prices and market volatility, potential defaults of borrowers or trading counterparties, the implementation of our strategic initiatives, the reliability of our risk management policies, procedures and methods, and other risks referenced in our filings with the U.S. Securities and Exchange Commission. Such factors are described in detail in our SEC Form 20-F of 20 March 2015 under the heading “Risk Factors”. Copies of this document are readily available upon request or can be downloaded from www.db.com/ir.